Renal Medullary HIF Prolyl Hydroxylases and Salt Sensitivity of Blood Pressure
肾髓质 HIF 脯氨酰羟化酶与血压的盐敏感性
基本信息
- 批准号:9094599
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-07 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:AftercareAntihypertensive AgentsBlood PressureCMV promoterChronicDactinomycinDataDefectDevelopmentEatingEndogenous FactorsEnzymesEquilibriumExcretory functionFunctional disorderFundingGenesGenetic TranscriptionHealthHypertensionHypoxia Inducible FactorImpairmentIn VitroKidneyLuciferasesMeasuresMediatingMediator of activation proteinMessenger RNAMicroRNAsModelingMolecularNatriuresisNitric Oxide SynthasePathogenesisPathway interactionsPlasmidsProcollagen-Proline DioxygenaseProductionProtein IsoformsProteinsRattusRegulationReporterSodiumSodium ChlorideSodium-Restricted DietSystemTestingTransfectionTransgenesUntranslated RegionsUrineWorkbHLH-PAS factor HLFbasecyclooxygenase 2heme oxygenase-1high salt dietin vivoinhibitor/antagonistinsightkidney medullamRNA DecaymRNA Transcript Degradationnormotensivenovelnovel therapeuticsoverexpressionpressurepreventresponsesalt intakesalt sensitivesalt sensitive hypertensionvector
项目摘要
DESCRIPTION (provided by applicant): Hypoxia inducible factor (HIF)-1alpha is a transcriptional factor that is highly expressed in the renal medulla and regulates many anti-hypertensive genes, such as heme oxygenase-1, cyclooxygenase-2 and nitric oxide synthase-2, in this kidney region. Prolyl hydroxylase domain-containing protein-2 (PHD2) is the major enzyme to promote the degradation of HIF-1alpha in the renal medulla. In the last funding period, we proved that high salt intake reduced PHD2 mRNA levels in the renal medulla, which consequently induced HIF-1alpha-mediated activation of anti-hypertensive genes. This PHD2/HIF-1alpha-mediated molecular adaptation in the renal medulla is important for the kidneys to remove extra Na+ loading and maintain normal blood pressure under high salt intake. The question remains: how does high salt intake reduce PHD2 mRNA? Our preliminary studies showed that high salt diet enhanced the degradation of PHD2 mRNA in the renal medulla and that microRNA miR-429 was probably the upstream mediator for high salt-induced enhancement of PHD2 mRNA decay: 1) among the microRNAs that target PHD2 mRNA, miR-429 levels were increased by high salt intake in the renal medulla; 2) miR-429 was shown to target PHD2 mRNA 3'-UTR; 3) miR-429 reduced PHD2 mRNA levels in vitro and in vivo. Moreover, miR-429 inhibitor blocked the high salt- induced decrease in PHD2 mRNA in the renal medulla and produced salt sensitive hypertension in normal rats. We also detected impairment in miR-429 in the renal medulla in Dahl salt-sensitive hypertensive (SS) rats. Based on these preliminary data, we hypothesize that miR-429 regulation of PHD2/HIF-1alpha-mediated activation of anti-hypertensive genes in the renal medulla contributes to renal salt adaptation and participates in the controls of renal Na+ handling and blood pressure. To test this hypothesis, we will first determine whether chronic renal adaptation to high salt intake is associated with an increase in miR-429, which decreases PHD2 levels and activates HIF-1alpha-mediated transcriptions of anti-hypertensive genes in the renal medulla in normal rats. We will then determine whether inhibition of miR-429 function to prevent PHD2 reduction and to diminish HIF-1alpha-mediated activation of anti-hypertensive genes in the renal medulla will blunt pressure natriuresis and impair renal Na+ handling, leading to salt sensitive hypertension in normal rats. Finally, we will determine whether salt-sensitive hypertension in Dahl SS rats is associated with the dysfunction in miR-429- mediated molecular adaptation related to PHD2/HIF-1alpha-pathway in the renal medulla and also investigate the mechanisms that cause the deficiency of renal medullary miR-429 in this hypertensive model. The proposed studies will reveal a novel molecular mechanism mediating renal adaptation to high salt intake and provide new insights into the pathogenesis of salt-sensitive hypertension.
描述(由申请人提供):缺氧诱导因子(HIF)-1 α是一种转录因子,在肾髓质中高度表达,并调节该肾区域的许多抗高血压基因,如血红素加氧酶-1、环氧合酶-2和一氧化氮合酶-2。含脯氨酰羟化酶结构域蛋白-2(PHD 2)是促进肾髓质中HIF-1 α降解的主要酶。在上一个资助期,我们证明高盐摄入降低了肾髓质中PHD 2 mRNA水平,从而诱导HIF-1 α介导的抗高血压基因激活。这种PHD 2/HIF-1 α介导的肾髓质分子适应对于肾脏在高盐摄入下清除额外的Na+负荷和维持正常血压是重要的。问题仍然存在:高盐摄入如何减少PHD 2 mRNA?我们的初步研究表明,高盐饮食促进了肾髓质中PHD 2 mRNA的降解,而microRNA miR-429可能是高盐诱导的PHD 2 mRNA降解增强的上游介质:1)在靶向PHD 2 mRNA的microRNA中,高盐摄入增加了肾髓质中miR-429的水平; 2)miR-429显示靶向PHD 2 mRNA 3 '-UTR; 3)miR-429在体外和体内降低PHD 2 mRNA水平。此外,miR-429抑制剂阻断了高盐诱导的肾髓质中PHD 2 mRNA的减少,并在正常大鼠中产生盐敏感性高血压。我们还检测到Dahl盐敏感性高血压(SS)大鼠肾髓质中miR-429的损伤。基于这些初步数据,我们假设miR-429调节PHD 2/HIF-1 α介导的肾髓质中抗高血压基因的激活有助于肾盐适应,并参与肾Na+处理和血压的控制。为了验证这一假设,我们将首先确定慢性肾脏对高盐摄入的适应是否与miR-429的增加有关,miR-429降低了PHD 2水平并激活了正常大鼠肾髓质中HIF-1 α介导的抗高血压基因的转录。然后,我们将确定抑制miR-429功能以防止PHD 2减少并减少肾髓质中HIF-1 α介导的抗高血压基因的激活是否会减弱压力性尿钠排泄并损害肾Na+处理,从而导致正常大鼠的盐敏感性高血压。最后,我们将确定Dahl SS大鼠的盐敏感性高血压是否与肾脏髓质中与PHD 2/HIF-1 α通路相关的miR-429介导的分子适应功能障碍相关,并研究在该高血压模型中导致肾脏髓质miR-429缺乏的机制。这些研究将揭示一种新的介导肾脏适应高盐摄入的分子机制,并为盐敏感性高血压的发病机制提供新的见解。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Infusion of Valproic Acid Into the Renal Medulla Activates Stem Cell Population and Attenuates Salt-Sensitive Hypertension in Dahl S Rats.
- DOI:10.1159/000478955
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Wang Z;Zhu Q;Wang W;Yi F;Li PL;Boini KM;Li N
- 通讯作者:Li N
Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla.
- DOI:10.1161/hypertensionaha.109.145896
- 发表时间:2010-05
- 期刊:
- 影响因子:0
- 作者:Wang Z;Zhu Q;Xia M;Li PL;Hinton SJ;Li N
- 通讯作者:Li N
Inhibition of microRNA-429 in the renal medulla increased salt sensitivity of blood pressure in Sprague Dawley rats.
- DOI:10.1097/hjh.0000000000001373
- 发表时间:2017-09
- 期刊:
- 影响因子:4.9
- 作者:Zhu Q;Hu J;Wang L;Wang W;Wang Z;Li PL;Boini KM;Li N
- 通讯作者:Li N
Implication of sphingosin-1-phosphate in cardiovascular regulation.
- DOI:10.2741/4458
- 发表时间:2016-06-01
- 期刊:
- 影响因子:0
- 作者:Li N;Zhang F
- 通讯作者:Zhang F
Hypoxia inducible factor-1α mediates the profibrotic effect of albumin in renal tubular cells.
- DOI:10.1038/s41598-017-15972-8
- 发表时间:2017-11-20
- 期刊:
- 影响因子:4.6
- 作者:Hu J;Wang W;Zhang F;Li PL;Boini KM;Yi F;Li N
- 通讯作者:Li N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ningjun Li其他文献
Ningjun Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ningjun Li', 18)}}的其他基金
Inhibition of fatty acid amide hydrolase as a novel strategy to prevent nephrotoxicity of cisplatin.
抑制脂肪酸酰胺水解酶作为预防顺铂肾毒性的新策略。
- 批准号:
10684803 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Inhibition of fatty acid amide hydrolase as a novel strategy to prevent nephrotoxicity of cisplatin.
抑制脂肪酸酰胺水解酶作为预防顺铂肾毒性的新策略。
- 批准号:
10513011 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertension
盐敏感性高血压中的肾 1-磷酸鞘氨醇受体 1
- 批准号:
10319594 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
Renal sphingosine-1-phosphate receptor 1 in salt-sensitive hypertension
盐敏感性高血压中的肾 1-磷酸鞘氨醇受体 1
- 批准号:
10064007 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
Molecular mechanism of hypertension-induced renal injury: the role of HIF-1alpha
高血压肾损伤的分子机制:HIF-1α的作用
- 批准号:
9383995 - 财政年份:2017
- 资助金额:
$ 38.13万 - 项目类别:
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension
盐敏感性高血压中的肾髓质干细胞生态位
- 批准号:
8207205 - 财政年份:2011
- 资助金额:
$ 38.13万 - 项目类别:
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension
盐敏感性高血压中的肾髓质干细胞生态位
- 批准号:
8386965 - 财政年份:2011
- 资助金额:
$ 38.13万 - 项目类别:
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension
盐敏感性高血压中的肾髓质干细胞生态位
- 批准号:
8024001 - 财政年份:2011
- 资助金额:
$ 38.13万 - 项目类别:
Renal Medullary Stem Cell Niche in Salt Sensitive Hypertension
盐敏感性高血压中的肾髓质干细胞生态位
- 批准号:
8584315 - 财政年份:2011
- 资助金额:
$ 38.13万 - 项目类别:
Renal medullary HIF prolyl hydroxylases and salt sensitivity of blood pressure
肾髓质HIF脯氨酰羟化酶与血压盐敏感性
- 批准号:
7841255 - 财政年份:2009
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
The role of antihypertensive agents in renal and vascular complications in a model of hypertension and diabetes
抗高血压药物在高血压和糖尿病模型中肾脏和血管并发症中的作用
- 批准号:
nhmrc : 145854 - 财政年份:2001
- 资助金额:
$ 38.13万 - 项目类别:
NHMRC Postgraduate Scholarships
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
- 批准号:
6125791 - 财政年份:1997
- 资助金额:
$ 38.13万 - 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
- 批准号:
2487342 - 财政年份:1997
- 资助金额:
$ 38.13万 - 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
- 批准号:
2839029 - 财政年份:1997
- 资助金额:
$ 38.13万 - 项目类别:
APPROACHES TO NATRIURETIC AND ANTIHYPERTENSIVE AGENTS
利尿钠和抗高血压药物的治疗方法
- 批准号:
6330091 - 财政年份:1997
- 资助金额:
$ 38.13万 - 项目类别:
Antihypertensive Agents of Kudzu: Possible Chemical Utilization of a Southeastern Pest Vine
葛根的抗高血压剂:东南部害虫藤蔓的可能化学利用
- 批准号:
7905238 - 财政年份:1979
- 资助金额:
$ 38.13万 - 项目类别:
Standard Grant